The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins

Biological Chemistry

Volumn 380, Issue 2, 1999, Pages 117-128

  Irminger Finger, Irmgard ^a   Siegel, Brian D ^b   Leung, Wai Choi ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BAP 1; BARD1; BRCA1; BRCT; Breast cancer; Cell cycle; DNA repair; Mutation; Ovarian cancer; Transcriptional transactivation

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; MYC PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN P53; RNA HELICASE; RNA POLYMERASE II;

BREAST CANCER; CANCER SUSCEPTIBILITY; CELL CYCLE; DNA REPAIR; FAMILIAL CANCER; GENE MUTATION; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 0032982976     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.019     Document Type: Review

References (88)

1. Abel, K.J., Xu, J., Yin, G-Y., Lyons, R.H., Meisler, M.H., and Weber, B.L. (1995). Mouse Brca1 localization, sequence analysis and identification of evolutionarily conserved domains. Hum. Mol. Genet. 4, 2265-2273.
2. Anderson, S.F., Schlegel, B.P., Nakajima, T., Wolpin, E.S., and Parvin, J.D. (1998). BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19, 254-256.
3. Andres, J.L., Fan, S., Turkel, G.J., Wang, J-A., Twu, N-F., Yuan, R.-Q., Lamszus, K., Goldberg, I.D., and Rosen, E.M. (1998). Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene 16, 2229-2241.
4. Ayi, T.-C., Tsan, J.T., Hwang L.-Y., Bowcock, A.M., and Baer, R. (1998). Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein. Oncogene 17, 2143-2148.
5. Blackwood, M.A., and Weber, B.L. (1998). BRCA1 and BRCA2: from molecular genetics to clinical medicine. J. Clin. Onc. 16, 1969-1977.
6. Bork, P., Hofmann, K., Bucher, P., Neuwald, A.F., Altschul, S.F., and Koonin, E.V. (1997). A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11, 68-76.
7. Boyd, M., Harris, F., Davidson, H.R., and Black, D.M. (1995). A human BRCA1 gene knockout. Nature 375, 541-542.
8. Boyd, J.M., Subramanian, T., Schaeper, U., La Regina, M., Bayley, S., and Chinnadurai, G. (1993). A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 12, 469-478.
9. 2-terminal BRCA1 RING finger domain. J. Biol. Chem. 273, 7795-7799.
10. Callebaut, I., and Mornon, J-P. (1997). From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400, 25-30.
11. Casey, G. (1997). The BRCA1 and BRCA2 breast cancer genes. Curr. Opin. Oncol. 9, 88-93.
12. Castilla, L.H., Couch, F.J., Erdos, M.R., Koskins, K.F., Calzone, K., Garber et al. (1994). Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat. Genet. 8, 387-391.
13. Chapman, M.S., and Verma, I.M. (1996). Transcriptional activation by BRCA1. Nature 382, 678-679.
14. Chen, J., Silver, D.P., Walpita, D., Cantor, S.B., Gazdar, A.F., Tomlinson et al. (1998). Stable Interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2, 317-328.
15. Chen, Y., Farmer, A.A., Chen, C.-F., Jones, D.C., Chen, P-L. and W.-H. Lee (1996). BRCA1 is a 220 kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res. 56, 3168-3172.
16. Couch, F.J., DeShano, M.L., Blackwood, M.A., Calzone, K., Stopfer, J., Campeau, L., Ganguly, A., Rebbeck, T., and Weber, B.L. (1997). BRCA1 mutations in women attending clinics that evalulate the risk of breast cancer. New Eng. J. Med. 336, 1409-1415.
17. Eisinger, F., Nogues, C., Birnbaum, D., Jacquemier, J., and Sobol, H. (1998). Low frequency of lymph-node metastasis in BRCA1-associated breast cancer. Lancet 351, 1633-1634.
18. Friedberg, E.C. (1996). Relationships between DNA repair and transcription. Ann. Rev. Biochem. 65, 15-42.
19. Friedman, L.S., Ostermeyer, E.A., Szabo, S., Dowd, P., Lynch, E.D., Rowell, S.E., and King, M.-C. (1994). Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat. Genet. 8, 399-404.
20. Gaffney, D.K., Brohet, R.M., Lewis, C.M., Holden, J.A., Buy, S.S., Neuhausen, S.L., et al. (1998). Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother. Oncol. 47, 129-136.
21. Gayther, S.A., Warren, W., Mazoyer, S., Russell, P.A., Harrington, P.A., Chiano, M., et al. (1995). Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat. Genet. 11, 428-433.
22. Gowen, L.C., Johnson, B.L., Latour, A.M., Sulik, K.K., and Koller, B.H. (1996). Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12, 191-194.
23. Gowen, L.C., Avrutskaya, A.V., Latour, A.M., Koller, B.H., and Leadon, S.A. (1998). BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281, 1009-1012.
24. Gudas, J.M., Li, T., Nguyen, H., Jensen, D., Raushcer III, F.J., and Cowan, K.H. (1996). Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Diff. 7, 717-723.
25. Hakem, R., de la Pompa, J.L., Sirard, C., Mo, R., Woo, M., Hakem, A. et al. (1996). The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009-1023.
26. 5-6 early embryonic lethality by p53 or p21 null mutation. Nat Genet 16, 298-302.
27. Hao Thai, T.H., Du, F., Tsan, J.T., Jin, Y., Phung, A., Spillman, M.A., et al. (1998). Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum. Mol. Genet. 7, 195-202.
28. Herman, J., Latif, F., Weng, Y., Lerman, M.I., Zbar, B., Liu, S., Samid, D., Duan, D.S., Gnarra, J.R., Linehan, W.M., and Baylin, S.B. (1994). Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 91, 9700-9704.
29. Holt, J.T., Thompson, M.E., Szabo, C., Robinson-Benion, C., Arteaga, C.L., King, M-C., and Jensen, R.A. (1996). Growth retardation and tumour inhibition by BRCA1. Nat. Genet. 12, 298-302.
30. Hsu, L.-C., and White, R.L. (1998). BRCA1 is associated with the centrosome during mitosis. Proc. Natl. Acad. Sci. 95, 12983-12988.
31. Humphrey, J.S., Salim, A., Erdos, M.R., Collins, F.S., Brody, L.C., and Klausner, R.D. (1997). Human BRCA1 inhibits growth in yeast: Potential use in diagnostic testing. Proc. Natl. Acad. Sci. USA 94, 5820-5825.
32. Iguchi-Ariga, S.M.M., and Schaffner, W. (1989). CpG methylation of the cAMP-responsive enhancer/promoter sequence TGAC-GTCA abolishes specific factor binding as well as transcriptional activation. Genes & Dev. 3, 612-619.
33. Irminger-Finger, I., Soriano, J.V., Vaudan, G., Montesano, R., and Sappino, A.-P. (1998). In vitro repression of Brca1-associated RING domain gene 1 (Bard1) induces phenotypic changes in mammary epithelial cells. J. Cell Biol. 143, 1329-1339.
34. Ivanov, E.L., and Haber, J.E. (1997). DNA repair: RAD alert. Current Biol. 7, R492-R495.
35. Jensen, D.E., Proctor, M., Marquis, S.T., Gardner, H.P., Ha, S.I., Chodosh, L.A. et al. (1998). BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16, 1097-1112.
36. Jernstrom, H., Johannsson, O., Borg, A., Ivarsson, H., and Olsson, H. (1998). BRCA1-positive patients are small for gestational age compared with their unaffected relatives. Eur. J. Cancer 34, 368-371.
37. Jin, Y., Xu, X.L., Yang, M-C.W., Wei, F., Ayi, T.-C., Bowcock, A.M., and Baer, R. (1997). Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in descrete nuclear domains. Proc. Natl. Acad. Sci. USA 94, 12075-12080.
38. Johannsson, O.T., Tdvall, I., Anderson, C., Borg, A., Barkardottir, R.B., Egilsson, V., and Olsson, H. (1997). Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur. J. Cancer 33, 362-371.
39. Kinzler, K.W., and Vogelstein, B. (1997). Cancer-susceptibility genes. Gate keepers and caretakers. Nature 386, 761-763.
40. 2-M cell cyclecontrol in human mammary epithelial cells. Cancer Res. 57, 3351-3355.
41. Lim, D.S., and Hasty, P. (1996). A Mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16, 7133-7143.
42. Liu, C.-Y., Flesken-Nikitin, A, Li, S., Zeng, Y., and Lee, W.-H. (1996). Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes & Dev. 10, 1835-1843.
43. Ludwig, T., Chapman, D.L., Papaioannou, V.E., and Efstratiadis, A. (1997). Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes and Development 11, 1226-1241.
44. Maldonado, E., Shiekhattar, R., Sheldon, M., Cho, H., Drapkin, R., Rickert, P., Lees, E., Anderson, C.W., Linn, S., and Reinberg, D. (1996). A human RNA polymerase II complex associated with SRB and DMA-repair proteins. Nature 381, 86-89.
45. Mancini, D.N., Rodenhiser, D.I., Ainsworth, P.J., O'Malley, F.P., Singh, S.M., Xing, W., and Archer, T.K. (1998). CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16, 1161-1169.
46. Marcus, J., Watson, P., Page, D.L., Narod, S.A., Lenoir, G.M., Tonin, P. et al. (1996). Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77, 697-709.
47. Merajver, S.D., Pham, T.M., Caduff, R.F., Chen, M., Poy, E.L., Cooney, K.A., Weber, B.L., Collins, F.S., Johnston, C., and Frank, T.S. (1995). Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet. 9, 439-443.
48. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B., and Sidransky, O. (1995). 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1, 686-692.
49. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harsham, K., Tavtigian, S. et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
50. Monteiro, A.N.A., August, A., and Hanafusa, H. (1996). Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA 93, 13595-13599.
51. Nibu, Y., Zhang., H., and Levine, M. (1998). Interaction of short-range repressors with Drosophila CtBP in the embryo. Science 280, 101-104.
52. Ohtani-Fujita, N., Fujita, T., Aoike, A., Osifchin, N.E., Robbins, P.D., and Sakai, T. (1992). CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 8, 1063-1067.
53. Ouchi, T., Monteiro, A.N.A., August, A., Aaronson, S.A., and Hanafusa, H. (1998). BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA 95, 2302-2306.
54. Ozcelik, H., To, M.D., Couture, J., Bull, S.B., and Andrulis, I.L. (1998). Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int. J. Cancer. 77, 1-6.
55. Poortinga, G., Watanabe, M., and Parkhurst, S.M. (1998). Drosophila CtBP: a Hairy-interacting protein required for embryonic segmentation and Hairy-mediated transcriptional repression. EMBO J. 17, 2067-2078.
56. Rajan, J.V., Wang, M., Marquis, S.T., and Chodosh, L.A. (1996). Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc. Natl. Acad. Sci. 93, 13078-13083.
57. Rao, V.N., Shao, N., Ahmad, M., Shyam, E., and Reddy, P. (1996). Antisense RNA to the putative tumor suppressor BRCA1 transforms mouse fibroblasts. Oncogene 12, 523-528.
58. Rhei, E., Bogomolniy, F., Federici, M.G., Maresco, D.L., Offit, K., Robson, M.E., Saigo, P.E., and Boyd, J. (1998). Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers. Cancer Res. 58, 3193-3196.
59. Rodenhiser, D.I., Chakraborty, P., Andrews, J., Ainsworth, P., Mancini, D., Lopes, E., and Singh, S. (1996). Heterogeneous point mutations in the BRCA1 breast cancer susceptibility gene occur in high frequency at the site of homonuclotide tracts, short repeats and methylatable CpG/CpNpG motifs. Oncogene 12, 2623-2629.
60. Scully, R., Ganesan, S., Brown, M., De Caprio, J.A., Cannistra, S.A., and Feunteun, J. (1996). Location of BRCA1 in human breast and ovarian cancer cells. Science 272, 123-124.
61. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D.M. (1997a). Association of BRCA1 with Rad51 in mitotic and meiotic Cells. Cell 88, 265-275.
62. Scully, R., Chen, J., Ochs, R.L., Keegan, K., Hoekstra, M., Feunteun, J., and Livingston, D.M. (1997b). Dynamic changes of BRCA1 subnuclear location and phosphorylation state are inititated by DNA damage. Cell 90, 425-235.
63. Scully, R., Anderson, S.F., Chao, D.M., Wei, W., Ye, L., Young, R.A., Livingston, D.M., and Parvin, J.D. (1997c). BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA 94, 5605-5610.
64. Shao, N., Chai, Y.L., Shyam, E., Reddy, P., and Rao, V.N. (1996). Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13, 1-7.
65. Sharan, S.K., Morimatsu, M., Albrecht, U., Lim, D-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804-810.
66. Snow, E.T. (1997). The role of DNA repair in development. Reprod. Toxicol. 11, 353-365.
67. Sobol, H., Stoppa-Lyonnet, D., Bressac-de-Paillerets, B., Peyrat, J.-P., Keranguseven, F., Janin, N. et al. (1996). Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers. Can. Res. 56, 3216-3219.
68. Wat1/CrP1. Nature 389, 187-190.
69. Soriano, J.V., Pepper, M.S., Nakamura, T., Orci, L., and Montesano, R. (1995). Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell. Sci. 108, 413-30.
70. Sourvinos, G., and Spandidos, D.A. (1998). Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem. Biophys. Res. Com. 245, 75-80.
71. Streisinger, G., Okada, Y., Emrich, J., Newton, J., Tsugita, A., Terzahgi, E., and lnouye, I. (1966). Frameshift mutations and the genetic code. Cold Spring Harbor Sym. Quant. Biol. 31, 77-86.
72. Struewing, J.P., Abeliovich, D., Peretz, T., Avishar, N., Kaback, M.M., Collins, F., and Brody, L.C. (1995). The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percentin Ashkenazi Jewish individuals. Nature Genet. 11, 198-200.
73. Suzuki, A., de la Pompa, J.L., Hakem, R., Elia, A., Yoshida, R., Mo, R., et al. (1997). Brca2 is required for embryonic cellular proliferation in the mouse. Genes & Dev. 11, 1242-1252.
74. Svetlova, M.P., Solovjeva, L.V., Nikiforov, A.A., Chagin, V.A., Lehmann, A.R., and Tomilin, N.V. (1998). Staurosporine-sensitive protein phosphorylation is required for postreplication DNA repair in human cells. FEBS Letters 428, 23-26.
75. Thompson, M.E., Jensen, R.A., Obermiller, P.S., Page, D.L., and Holt, J.T. (1995). Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 9, 444-450.
76. Tirkkonen, M., Johannsson, O., Agnarsson, B.A., Olsson, H., Ingvarsson, S., Karhuy, R. et al. (1997). Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germline mutations. Cancer Res. 57, 1222-1227.
77. Torres-Ramos, C.A., Yoder, B.L., Burgers, P.M.J., Prakash, S., and Prakash, L. (1996). Requirement of proliferating cell nuclear antigen in RAD6-dependent postreplicational DNA repair. Proc. Natl. Acad. Sci. USA 93, 9676-9681.
78. Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y., and Morita, T. (1996). Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA 93, 6236-6240.
79. Vaughn, J.P., Davis, P.L., Jarboe, M.D., Huper, G., Evans, A.C., Wiseman, R. W. et al. (1996). BRCA1 Expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Diff. 7, 711-715.
80. Vaurs-Barriere, C., Vidal, V., Penault-Llorca, F., Kwiatkowski, F., Maugard, C., and Bignon, Y. (1998). Pathology of sporadic breast tumors with LOH at the BRCA1 locus: correlation with histopathological features specific to familial BRCA1 tumors and absence of microsatellite instability. Int. J. Oncol. 12, 1373-1378.
81. Wang, H., Shao, N., Ding, Q.M., Cui, J-q., Reddy, E.S.P., and Rao, V.N. (1997). BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15, 143-157.
82. Wang, Q., Zhang, H., Kajino, K., and Greene, M.I. (1998). BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene 17, 1939-1948.
83. Wu, L.C., Wang, Z.W., Tsan, J.T., Spillman, M.A., Phung, A., Xu, X.L., Yang, M-C.W., Hwang, L-Y., Bowcock, A.M., and Baer, R. (1996). Identification of a RING protein that can interact in vivo with the 8RCA1 gene product. Nat. Genet. 14, 430-440.
84. Xu, C-F., Brown, M.A., Chambers, J.A., Griffiths, B., Nicolai, H., and Solomon, E. (1995). Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum. Mol. Gen. 4, 2259-2264.
85. Xu, C-F., Chambers, J.A., and Solomon, E. (1997). Complex regulation of the BRCA1 gene. J. Biol. Chem. 272, 20994-20997.
86. Yu, X., Wu, L.C., Bowcock, A.M., Aronheim, A., and Baer, R. (1998). The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273, 25388-25392.
87. Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Zhang, H., Bi, D., Weber, B.L., and El-Deiry, W.S. (1998). BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16, 1713-1721.
88. Zhang, X., Morera, S., Bates, P.A., Whitehead, P.C., Coffer, A.I., Hainbucher, K. et al. (1998). Structure of an XRCC1 BRCT domain: a new protein-protein interaction molecule. EMBO J. 17, 6404-6411.